Fifth Third Wealth Advisors’s Halozyme HALO Stock Holding History

Fifth Third Wealth Advisors’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$342K	Sell	4,364 -583	-12%	-$39.8K	0.01%	646
2026 Q1	$320K	Buy	4,947 +733	+17%	+$51.7K	0.01%	574
2025 Q4	$284K	Sell	4,214 -45	-1%	-$3.03K	0.01%	609
2025 Q3	$312K	Sell	4,259 -35	-0.8%	-$2.33K	0.01%	538
2025 Q2	$223K	Buy	4,294 +13	+0.3%	+$740	0.01%	664
2025 Q1	$273K	Buy	4,281 +16	+0.4%	+$929	0.01%	527
2024 Q4	$204K	Sell	4,265 -65	-2%	-$3.33K	0.01%	692
2024 Q3	$248K	Buy	4,330 +34	+0.8%	+$1.95K	0.02%	551
2024 Q2	$225K	Buy	+4,296	New	+$188K	0.02%	544

Other funds holding HALO

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

KWM

Koa Wealth Management Encinitas, California $147M AUM 18.41% 1-Year Est. Return

AAM

Augustine Asset Management Jacksonville, Florida $494M AUM 76.22% 1-Year Est. Return

Cooper Investors Melbourne, Victoria, Australia $218M AUM 0.39% 1-Year Est. Return

Fifth Third Wealth Advisors's HALO Position: Q2 2026 in Review

Fifth Third Wealth Advisors reduced its Halozyme (HALO) stake by 12% in Q2 2026, selling an estimated $39.8K and leaving 4,364 shares worth $342K. The position accounts for 0.01% of the portfolio, ranked #646.

Fifth Third Wealth Advisors first reported a position in HALO in Q2 2024 and has held it in 9 quarters since. 102 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Fifth Third Wealth Advisors held 4,364 shares of Halozyme worth $342K as of Q2 2026.
Fifth Third Wealth Advisors sold 583 Halozyme shares in Q2 2026, an estimated $39.8K.
Halozyme made up 0.01% of Fifth Third Wealth Advisors's portfolio in Q2 2026, its #646 holding.
Fifth Third Wealth Advisors first reported a position in Halozyme in Q2 2024 and has held it in 9 quarters since.
102 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.